Selexipag: A New Treatment Agent for Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a rare disease which is characterized by the progressive increase of pulmonary arterial pressure. PAH can lead to right cardiac insufficiency and death. Conventional and other treatment modalities that target the physiopathological and etiopathological causes...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Meandros medical and dental journal 2019-04, Vol.20 (1), p.1-6
Hauptverfasser:	Yazıcı, Onur, Güngör, Hasan
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioavailability Blood pressure Drug dosages Hypertension Prostacyclin Pulmonary arteries Pulmonary hypertension Rare diseases Tıp Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!